Edoardo Barvas

ORCID: 0000-0003-1011-598X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • SARS-CoV-2 and COVID-19 Research
  • Functional Brain Connectivity Studies
  • COVID-19 Clinical Research Studies
  • Vaccine Coverage and Hesitancy
  • EEG and Brain-Computer Interfaces
  • Dementia and Cognitive Impairment Research
  • Long-Term Effects of COVID-19
  • Facial Nerve Paralysis Treatment and Research
  • Visual Attention and Saliency Detection
  • Memory Processes and Influences
  • Neuroscience and Neuropharmacology Research
  • Memory and Neural Mechanisms
  • Digital Imaging for Blood Diseases
  • Influenza Virus Research Studies
  • Image and Object Detection Techniques
  • Neurological disorders and treatments
  • Multiple Sclerosis Research Studies
  • SARS-CoV-2 detection and testing
  • Handwritten Text Recognition Techniques
  • Peripheral Neuropathies and Disorders
  • COVID-19 and Mental Health
  • Spatial Neglect and Hemispheric Dysfunction
  • Autism Spectrum Disorder Research
  • Neural dynamics and brain function
  • Viral Infections and Immunology Research

University of the Republic of San Marino
2019-2022

University of Trento
2020-2021

Ospedale di Stato della Repubblica di San Marino
2021

Ospedale Infermi di Rimini
2020

Center for Neuroscience and Cognitive Systems
2020

Abstract The dynamics of the resting brain exhibit transitions between a small number discrete networks, each remaining stable for tens to hundreds milliseconds. These functional microstates are thought be building blocks spontaneous consciousness. electroencephalogram (EEG) is useful tool imaging microstates, and EEG microstate analysis can potentially give insight into altered underpinning cognitive impairment in disorders such as Alzheimer’s disease (AD). Since non-invasive relatively...

10.1038/s41598-020-74790-7 article EN cc-by Scientific Reports 2020-10-19
Simone Beretta Viviana Cristillo Giorgia Camera Carlo Morotti Colleoni Gaia Pellitteri and 95 more Beatrice Viti Elisa Bianchi Stefano Gipponi Maria Grazia Grimoldi Mariarosaria Valente Susanna Guttmann Maria Sofia Cotelli Pasquale Palumbo Giorgio Gelosa Stefano Meletti Cristina Schenone Donatella Ottaviani Massimo Filippi Andrea Zini Paola Basilico Lucia Tancredi Pietro Cortelli M. Braga Valeria De Giuli Serenella Servidei Damiano Paolicelli Federico Verde Stefano Caproni Antonio Pisani Vincenzina Lo Re Luca Massacesi Daria Roccatagliata Paolo Manganotti Daniele Spitaleri Anna Maria Formenti Marta Piccioli Lidia Marino Paola Polverino Umberto Aguglia Raffaele Ornello Elisabetta Perego Gabriele Siciliano Paola Merlo Marco Capobianco Leonardo Pantoni Alessandra Lugaresi Stefania Angelocola Anna De Rosa Maria Sessa Ettore Beghi Elio Clemente Agostoni Salvatore Monaco Alessandro Padovani Alberto Priori Vincenzo Silani Gioacchino Tedeschi Carlo Ferrarese Andrea Pilotto Stefano Cotti Piccinelli Susanna Lazzari G Negro Giulia Sofia Cereda R Infante Ginevra Giovannelli Claudia Cutellé Lorenzo Tinti Susanna Diamanti Gaia Fanella Nicola Rifino Lucio Tremolizzo Giovanni Ermanis Fedra Kuris Roberto Sartor Francesco Bax Gian Luigi Gigli Edoardo Barvas Mirco Volpini Roberto Frusciante Mariaeva Bernardi Marinella Turla Raffaella Valenti Raffaella Valenti Lorenzo Kiferle Silvia Pradella Alessandro Innocenti Ludovico Ciolli Niccolò Orlandi Gabriele Vandelli Marco Mazzoli Luana Benedetti Matteo Pardini Stefano Grisanti Erica Biassoni Corrado Cabona Angelo Schenone Federica Boso Federica Agosta Mario Orrico Luisa Roveri Giacomo Sferruzza

<h3>Background and Objective</h3> A variety of neurological disorders has been reported as presentations or complications COVID-19 infection. The objective this study was to determine their incidence dynamics long-term functional outcome. <h3>Methods</h3> Neuro-COVID Italy a multicentre, observational, cohort with ambispective recruitment prospective follow-up. Consecutive hospitalized patients presenting new associated infection (neuro-COVID), independently from respiratory severity, were...

10.1212/wnl.0000000000207534 article EN cc-by Neurology 2023-07-06

In August 2020, Sputnik V was registered as Gam-COVID-Vac by the Russian Ministry of Health, and since December 2020 it has been distributed in 61 countries worldwide. On 25 February 2021, Republic San Marino started its vaccination campaign, which includes V. Our aim to describe adverse events following immunization (AEFIs) with this vaccine through participant-based active surveillance country.Beginning from 4 March 8 April a nationwide study conducted on Marino's population aged 18-89...

10.1016/j.eclinm.2021.101027 article EN cc-by-nc-nd EClinicalMedicine 2021-07-08

Emotion processing impairment is a common non-motor symptom in Parkinson's Disease (PD). Previous literature reported conflicting results concerning, particular, the performance for different emotions, relation with cognitive and neuropsychiatric symptoms affected stage of processing. This study aims at assessing emotion recognition discrimination PD. Recognition six facial expressions was studied order to clarify its relationship motor, symptoms. Sensitivity discriminating happy fearful...

10.1111/jnp.12209 article EN Journal of Neuropsychology 2020-04-22

Objectives: Neurocognitive disorders in Parkinson’s disease (PD) are common and heterogeneous. The aim of this study was to use a data-driven method describe different cognitive phenotypes PD explore anxiety, depression, motor disturbances across the profiles. Method: Latent profile analysis applied neuropsychological performances 65 patients with idiopathic assessed by means battery tests that encompass measures attention, memory, executive functions, social cognition, language,...

10.1037/neu0000737 article EN Neuropsychology 2021-05-01

Abstract OBJECTIVE To assess the safety of Sputnik V (Gam-COVID-Vac) COVID-19 vaccine through participant-based active surveillance from Republic San Marino vaccination campaign. DESIGN AND SETTING This is a nation-wide cohort study in to monitor any Adverse Events Following Immunisation (AEFI) with V. PARTICIPANTS Adults aged 18-89 years who had at least one dose administered and responded or accessed an e-questionnaire sent via email, QR-code were live/phone interviewed about 7 days after...

10.1101/2021.05.03.21256509 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2021-05-05

Abstract Acquired prosopagnosia is usually a consequence of bilateral or right hemisphere lesions and often associated with topographical disorientation dyschromatopsia. Left temporo-occipital sometimes result in face recognition disorder but context visual object agnosia spared familiarity feelings for faces, left-handers. We describe patient left hemorrhagic lesion unexpectedly resulting deficit familiarity, which could represent mild form associative prosopagnosia. Our failed to feel even...

10.1007/s10072-020-04581-5 article EN cc-by Neurological Sciences 2020-07-09

Gam-COVID-Vac is the world's first registered vector vaccine against COVID-19 based on a combination of two heterologous adenoviruses. It was chosen by Republic San Marino as main tool in its vaccination campaign, which started 25 February 2021. Our aim to build up ROCCA study, focused older population, describing adverse effects following immunisation (AEFIs) rates and characteristics all age groups for time real-world context.An active surveillance study recipients at least one dose...

10.1016/j.eclinm.2022.101468 article EN cc-by-nc-nd EClinicalMedicine 2022-05-20

The Republic of San Marino COVID-19 vaccination campaign used Gam-COVID-Vac and Pfizer-BioNTech vaccines. To assess adverse events following immunization (AEFIs), approximately 6000 vaccine recipients were monitored by the ROCCA study, including subgroups with Parkinson's Disease (PD) Multiple Sclerosis (MS). purpose this study is to evaluate short-term AEFIs through a 1-month follow-up. We conducted longitudinal using active surveillance safety profiles vaccines in PD MS patients....

10.3390/vaccines10030370 article EN cc-by Vaccines 2022-02-26

Abstract INTRODUCTION Elucidating and better understanding functional biomarkers of Alzheimer’s disease (AD) is crucial. By analysing a detailed longitudinal dataset, this study aimed to create model-based toolset characterise understand the conversion mild cognitive impairment (MCI) AD. METHODS EEG, MRI, neuropsychological data were collected from participants in San Marino: AD (n = 10), MCI 20), controls 11). Across two additional years, classified as converters or non-converters. RESULTS...

10.1101/2024.12.16.628666 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2024-12-17

Abstract Introduction Electroencephalogram (EEG) is a potentially useful clinical tool for aiding diagnosis of Alzheimer’s disease (AD). We hypothesized we can increase the accuracy EEG AD using microstates, which are epochs quasi-stability at millisecond scale. Methods was collected from two independent cohorts and control participants cohort mild cognitive impairment (MCI) patients with four-year follow-up. Microstates were analysed, including novel measure complexity. Results Microstate...

10.1101/833244 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2019-11-14

A variety of neurological disorders has been reported as presentations or complications COVID-19 infection. The NEURO-COVID study is a multi-center cohort associated with conducted in 51 centers Italy, sponsored by the Italian Society Neurology (SIN). We present an interim analysis hospitalized adult patients infection, defined positive SARS-CoV-2 test independently from clinical severity, and concomitant newly diagnosed disorders. Patients were recruited March 1, 2020 to 26, 2021 18...

10.1016/j.jns.2021.117804 article EN other-oa Journal of the Neurological Sciences 2021-10-01
Coming Soon ...